A PHP Error was encountered

Severity: Notice

Message: Only variable references should be returned by reference

Filename: core/Common.php

Line Number: 257

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/biomagaz/cwcms_core/system/core/Exceptions.php:185)

Filename: core/Security.php

Line Number: 188

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/biomagaz/cwcms_core/system/core/Exceptions.php:185)

Filename: libraries/Session.php

Line Number: 672

BIO Magazine - Modern food biotechnology, human health and development: an evidence-based study Δεκέμβριος 2015
Δεκέμβριος 2015 No38

BIO Science

Modern food biotechnology, human health and development: an evidence-based study
Modern food biotechnology, human health and development: an evidence-based study

Executive Summary

This study was commissioned by the World Health Organization (WHO) to establish a knowledge base for evaluating the application of modern biotechnology in food production. The study does not seek to address all issues and evidence in detail, but rather aims to place in context the overall impact of this technology on human health and development. The study reviews evidence in several broad areas related to the use of genetically modified (GM) organisms in the food supply (GM foods), including a review of GM food products currently available, the assessment of risks and benefits, the broader impact on societies, and the existing regulatory capacity in countries. The evidence was collected and collated by WHO with the support of a background group of external experts (list of experts - annex 1). Data for the study were gathered through traditional methodology as well as through an open questionnaire and an Internet-based electronic discussion process. Preliminary results were discussed at a broad stakeholder meeting held in 2003 (list of participants - annex 1), informing further data search and revision.

The first GM food (delayed-ripening tomato) was introduced on the US market in the mid-1990s. Since then, GM strains of maize, soybean, rape and cotton have been adopted by a number of countries and marketed internationally. In addition, GM varieties of papaya, potato, rice, squash and sugar beet have been trialed or released. It is estimated that GM crops cover almost 4% of total global arable land.

The development of GM organisms (GMOs) offers the potential for increased agricultural productivity or improved nutritional value that can contribute directly to enhancing human health and development. From a health perspective, there may also be indirect benefits, such as reduced agricultural chemical usage and enhanced farm income, and improved crop sustainability and food security, particularly in developing countries. Contradictory findings for such benefits sometimes reflect different regional or agricultural conditions.

The use of GMOs may also involve potential risks for human health and development. Many genes used in GMOs have not been in the food supply before. While new types of conventional food crops are not usually subject to safety assessment before marketing, assessments of GM foods were undertaken before the first crops were commercialized. To provide international consistency in the assessment of GM foods, principles developed by the Codex Alimentarius Commission (a joint programme of WHO and the Food and Agriculture Organization of the United Nations; FAO) now cover food safety, while the Cartagena Protocol on Biosafety covers environmental safety of GMOs. Many countries have established specific premarket regulatory systems in accordance with this international guidance that require a case-by-case risk assessment of each GM food. Risk assessment methodology undergoes continuous improvements, a fact that is recognized by the Codex principles, including the need for risk assessments to consider both the intended and unintended effects of such foods in the food supply. GM foods currently traded on the international market have passed risk assessments in several countries and are not likely, nor have been shown, to present risks for human health.

Although risk-assessment systems have been in use for some time, the perception of GM food among consumers has not always recognized these assessments. One explanation is that many national foodsafety systems have had problems performing good risk communication in this area. In many countries, social and ethical considerations may cause also resistance to modifications which interfere with genes. These conflicts often reflect deeper issues related to the interaction of human society with nature — issues that should be taken seriously in any communication effort. However, while in many regions, food is clearly considered part of historical identity and societal life, scepticism towards GM food is not necessarily linked to traditionalism or to absence of knowledge about this new technology. Investigations of public perception indicate that the sceptical consumer will acknowledge arguments both for and against GM food and, in general, does not demand ‘zero risk’. Likewise, it has been seen that critical attitudes towards GM food are not necessarily linked to a negative attitude towards the use of biotechnology as such, as demonstrated by a generally positive attitude towards the use of biotechnology in modern medicine. The issue of benefit to society therefore seems to constitute an important aspect related to acceptance of new technology.

Intellectual property rights are an important part of the GM food debate. Problems of assuring equal access to genetic resources, sharing benefits on a global level, and avoiding monopolization exist for GM food as for other uses of gene technology. Related to this are concerns about a growing influence of the chemical industry in seed markets. Sustainable agriculture and biodiversity are likely to benefit most when a rich variety of crops are planted, and a potential exclusive use of certain chemicalresistant GM crops could be seen to create dependency.

Conflicting assessments and incomplete substantiation of the benefits, risks and limitations of GM food have added to existing controversies. During a famine situation in southern Africa in 2002, the reluctance among several recipient countries to receive GM food aid was not primarily linked to health or environment issues, but to socioeconomic, ownership and ethical issues. Such controversies have not only highlighted the wide range of opinions within and between Member States, but also the existing diversity in regulatory frameworks and principles for assessing the benefits and risks of GM food. In addition, many developing countries cannot afford to build the separate capacities required for effective regulation of GM foods, which again underlines the benefits that could be derived from international work for broader evaluations of GM food applications.

At the international level, 15 legally binding instruments and non-binding codes of practice address some aspect of GMO regulation or trade. Such sector-based regulations increase the already overstretched capacity of developing countries, and present challenges to develop a fully coherent policy and regulatory framework for modern biotechnology. This study makes the case for the need for an evidence base to facilitate a more coherent evaluation of the application of modern food biotechnology and the use of GM foods. Such an evidence base should: deal with the assessment of human health and environmental risk as well as benefit; evaluate socioeconomic factors, including intellectual property rights; and consider ethical aspects. International harmonization in all these areas is a prerequisite for the prudent, safe and sustainable development of any new technology, including the use of biotechnology to produce food. Work towards such harmonization can only move forward through inter-sectoral collaboration and would therefore necessarily extend beyond the WHO mandate into the mandates of several other international organizations. This report should be seen as one possible starting point for further inter-sectoral discussions.

Read the rest of the report

http://www.who.int/foodsafety/publications/biotech/biotech_en.pdf

<< Επιστροφή στην λίστα

© BIO | info@biomagazine.gr

Powered by CreativeWorks